Corebridge Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-156,905
Closed -$48.9M 148
2025
Q1
$48.9M Sell
156,905
-5,443
-3% -$1.61M 0.28% 50
2024
Q4
$42.3M Sell
162,348
-2,198
-1% -$652K 0.23% 61
2024
Q3
$53M Sell
164,546
-16,519
-9% -$5.4M 0.28% 44
2024
Q2
$56.6M Buy
+181,065
New +$53.2M 0.31% 40

Other funds holding AMGN

Corebridge Financial's AMGN Position: Q2 2025 in Review

Corebridge Financial sold out of Amgen (AMGN) in Q2 2025, closing a stake of 156,905 shares — an estimated $48.9M sold.

Corebridge Financial first reported a position in AMGN in Q2 2024 and held it in 4 quarters. The position peaked at $56.6M in Q2 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Corebridge Financial reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 156,905 Amgen shares in Q2 2025, an estimated $48.9M.
  • Corebridge Financial first reported a position in Amgen in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Amgen position peaked at $56.6M in Q2 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.